Vident Investment Advisory, LLC Abb Vie Inc. Transaction History

Vident Investment Advisory, LLC

$0
Q3 2023

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $2.04 Million - $2.53 Million	15,369 Added 8.68%	192,442 $25.9 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $4.46 Million - $5.14 Million	30,837 Added 21.09%	177,073 $28.2 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $1.76 Million - $2.11 Million	12,710 Added 9.52%	146,236 $23.6 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $137,431 - $157,624	-1,024 Reduced 0.76%	133,526 $16.8 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $2.53 Million - $3.22 Million	-18,400 Reduced 12.03%	134,550 $20.6 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $1.22 Million - $1.51 Million	-9,246 Reduced 5.7%	152,950 $24.8 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $4.78 Million - $6.05 Million	44,486 Added 37.79%	162,196 $22 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $1.68 Million - $1.91 Million	15,830 Added 15.54%	117,710 $12.7 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $8.17 Million - $9.1 Million	77,612 Added 319.81%	101,880 $11.5 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $1.72 Million - $1.9 Million	-16,861 Reduced 41.0%	24,268 $2.63 Million
Q4 2020 Feb 08, 2021	SELL	$80.49 - $108.67 $3.02 Million - $4.08 Million	-37,582 Reduced 47.75%	41,129 $4.41 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $145,961 - $171,310	1,699 Added 2.21%	78,711 $6.89 Million
Q2 2020 Jul 17, 2020	BUY	$73.37 - $98.18 $2.19 Million - $2.93 Million	29,865 Added 63.34%	77,012 $7.56 Million
Q1 2020 May 12, 2020	BUY	$64.5 - $97.79 $1.58 Million - $2.4 Million	24,551 Added 108.65%	47,147 $3.59 Million
Q4 2019 Feb 11, 2020	BUY	$72.13 - $90.25 $6,275 - $7,851	87 Added 0.39%	22,596 $2 Million
Q3 2019 Nov 13, 2019	SELL	$62.98 - $75.72 $207,519 - $249,497	-3,295 Reduced 12.77%	22,509 $1.7 Million
Q2 2019 Aug 12, 2019	BUY	$65.7 - $83.98 $345,384 - $441,482	5,257 Added 25.59%	25,804 $1.88 Million
Q1 2019 May 08, 2019	BUY	$77.14 - $90.79 $30,624 - $36,043	397 Added 1.97%	20,547 $1.66 Million
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $238,065 - $293,598	3,058 Added 17.89%	20,150 $1.86 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $29,251 - $32,518	329 Added 1.96%	17,092 $1.62 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $332,006 - $392,838	3,698 Added 28.3%	16,763 $1.55 Million
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $457,289 - $612,353	-4,970 Reduced 27.56%	13,065 $1.21 Million
Q4 2017 Feb 15, 2018	BUY	$89.56 - $98.21 $388,779 - $426,329	4,341 Added 31.7%	18,035 $1.74 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $956,525 - $1.22 Million	13,694	13,694 $1.22 Million

Others Institutions Holding ABBV

# of Institutions

3,795

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.82M

Vanguard Group Inc Valley Forge, PA

171M
Shares

$34 Billion
0.57% of portfolio
Black Rock Inc. New York, NY

136M
Shares

$27.2 Billion
0.54% of portfolio
State Street Corp Boston, MA

77.8M
Shares

$15.5 Billion
0.59% of portfolio
Jpmorgan Chase & CO New York, NY

52.1M
Shares

$10.4 Billion
0.84% of portfolio
Capital International Investors Los Angeles, CA

38.6M
Shares

$7.7 Billion
1.4% of portfolio

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $353B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Account